Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Adverse cardiac remodelling results from an insult such as myocardial infarction, or as seen in Heart Failure (HF), maladaptive neurohormonal activation. Reverse remodelling describes improvement in cardiac geometry; the left ventricle (LV) recovers more normal structure with improved function and prognosis. Cardiovascular Magnetic Resonance imaging (CMR) allows gold standard assessment of LV volumes and function, diffuse and focal fibrosis and estimation of extracellular volume (ECV) by T1 mapping. Purpose Elevated T1 and ECV values are associated with worse outcome in many cardiac conditions. We conducted the first prospective study to investigate whether T1 mapping and ECV can predict cardiac reverse remodelling in response to treatment, in a cohort of patients hospitalised with a new HF diagnosis. Methods This was a single centre observational study. Inclusion criteria were admission with new HF, LVEF ≤50% or elevated NTproBNP and being treated with intravenous furosemide. Only patients with Heart Failure with reduced Ejection Fraction (HFrEF) and EF <40% on baseline echocardiography were included in this analysis. 36 consecutive eligible participants were included and had both echocardiogram and CMR studies to establish anatomy, function, and myocardial tissue characteristics at baseline. Participants were treated according to international HF guidelines and underwent reviews and repeat echocardiography at 6, 12–18 and 24–30 months. "Responders" to guideline directed HFrEF therapy were defined as those who had an increase in LVEF of ≥10% to a value of ≥40% between their baseline and latest follow-up echocardiogram. Baseline CMR volumes, function, presence of Late Gadolinium Enhancement (LGE), septal and whole heart T1 and ECV values were compared between responder and non-responder groups. Results Median follow-up was 26 months. 27 (75%) participants were responders to therapy. There were no differences in baseline characteristics between groups. There was high uptake of HFrEF medical therapy in both groups. (Table 1) There was no significant difference found between septal or whole heart T1 or ECV values between responder and non-responder groups. There was a trend towards lower whole heart ECV values (29% vs. 35%; p = 0.06) in the responder group but this did not reach statistical significance. (Figure 1) Overall, there was no difference in rates of LGE presence between groups but there was a significantly higher proportion of participants with non-ischaemic LGE pattern in the responder group compared to non-responder group (48% vs 11%; p = 0.05). Conclusions In this cohort of patients hospitalised with a new HFrEF diagnosis, the majority demonstrated reverse remodelling in response to therapy by 26 months. Whole heart ECV (%) as a surrogate marker for fibrosis calculated by whole heart T1 mapping may play a role in understanding which patients are likely to respond to HF therapy but further larger studies are required.

Role of Myocardial Extracellular Volume Fraction Measured with Magnetic Resonance Imaging in the Prediction of Left Ventricular Functional Outcome after Revascularization of Chronic Total Occlusion of Coronary Arteries

Extracellular Volume Fraction for the Assessment of Myocardial Functional Outcome after Revascularization in the Patients with Coronary Chronic Total Occlusion

Myocardial Extracellular Volume Fraction Measurement in Chronic Total Coronary Occlusion: Association with Myocardial Injury, Angiographic Collateral Flow, and Functional Recovery.

Effect of Breviscapine on Recovery of Viable Myocardium and Left Ventricular Remodeling in Chronic Total Occlusion Patients after Revascularization: Rationale and Design for a Randomized Controlled Trial

Reply: Prediction of the Left Ventricular Functional Outcome by Myocardial Extracellular Volume Fraction Measured Using Magnetic Resonance Imaging; Methodological Issue

Extracellular Volume Fraction in Coronary Chronic Total Occlusion Patients.

Circulating CD34+VEGFR-2+ Endothelial Progenitor Cells Correlate with Revascularization-Mediated Long-Term Improvement of Cardiac Function in Patients with Coronary Chronic Total Occlusions

Value of myocardial regional perfusion on long-term function in collateral-dependent myocardium.

[Association Between Collateral Circulation and Myocardial Viability Evaluated by Cardiac Magnetic Resonance Imaging in Patients with Coronary Artery Chronic Total Occlusion].

Incremental prognostic value of cardiovascular magnetic resonance imaging in patients with severe LV dysfunction undergoing coronary artery bypass grafting

Agreement in Left Ventricular Function Measured by Echocardiography and Cardiac Magnetic Resonance in Patients with Chronic Coronary Total Occlusion

Prognostic Value of Cardiac Magnetic Resonance Imaging Parameters in Left Ventricular Noncompaction with Left Ventricular Dysfunction

Associate variables of coronary computed tomographic angiography-derived extracellular volume fraction and cardiac magnetic resonance-derived late-gadolinium enhancement

Iodine-based extracellular volume for evaluating myocardial status in patients undergoing percutaneous coronary intervention for acute myocardial infarction by using dual-layer spectral detector computed tomography: a comparison study with magnetic resonance

Computed tomography-derived myocardial extracellular volume as a prognosis predictor in patients with severe aortic stenosis

Quantitation of Diffuse Myocardial Fibrosis Using Cardiac CT in Heart Failure: a Pilot Study

Myocardial extracellular volume quantification with computed tomography—current status and future outlook

The role of T1 mapping and Extracellular Volume (ECV) in predicting cardiac reverse remodelling and response to Heart Failure with reduced Ejection Fraction (HFrEF) therapy

Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation

T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy

Clinical Outcome and Left Ventricular Remodeling in Ami Patients with Insufficient Myocardial Reperfusion after Recanalization